SecBot SecBot
PRESS-RELEASE ·Filed May 11, 2026

MGNX

MacroGenics, Inc.
MIXED
Impact 6/10
Horizonmonths Processed6mo ago WireGlobeNewswire
Press release · Announcement
Actionable Insight ◆ Mixed

The $122.5M upfront provides near-term cash runway extension without dilution, but the sale of manufacturing capabilities signals a shift to a more asset-light model. Monitor Q3 2026 closing and any pipeline updates (e.g., lorigerlimab data) that could drive re-rating.

DirectionMixed
Confidencehigh
Horizonmonths

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$3.52
T+0 close · May 11, 2026 · via day close
Latest settled
+13.92%
T+60 · $4.01
Vs SPY
+9.54%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 12 $3.52entry
  2. T+1 · 6mo ago 0.00%α −0.54% · $3.52
  3. T+5 · 6mo ago +23.58%α +23.50% · $4.35
  4. T+20 · 5mo ago +9.94%α +11.67% · $3.87
  5. T+60 · 3mo ago +13.92%α +9.54% · $4.01

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

MacroGenics is selling its GMP drug substance manufacturing operations to Bora Pharmaceuticals for a $122.5 million upfront payment. The deal transfers the Rockville, MD facility (11,000L capacity), Frederick warehouse, and ~140 employees to Bora, while MacroGenics retains a supply arrangement for its pipeline needs. This non-dilutive capital infusion supports the company's pipeline advancement but reflects a strategic pivot away from internal manufacturing.

Key Financial Metrics

Deal Value
$122.5M

Key Facts

  • Upfront payment of $122.5 million from Bora Pharmaceuticals upon closing.
  • Transfer of Rockville, MD manufacturing site (11,000L capacity) and Frederick, MD warehouse.
  • Approximately 140 MacroGenics employees expected to be hired by Bora.
  • MacroGenics will have a supply arrangement with Bora for process development and drug substance production.
  • Transaction expected to close in Q3 2026.
  • Moelis & Company and Sidley Austin advised MacroGenics; Jones Day advised Bora.

Financial Impact

$122.5 million upfront payment, non-dilutive capital for pipeline funding.

cashoperating expensescapital expenditure

Risk Factors

  • Closing conditions may delay or prevent transaction completion.
  • Loss of internal manufacturing control could increase dependency on Bora for supply.
  • Pipeline setbacks (e.g., clinical trial failures) could erode the value of the capital infusion.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
54% bullish (13 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3292410

Track record

21 reports on MGNX

Performance horizon

4 of 6 bullish or bearish reports moved the stock their way by T+60. Best: +130.41% at T+60 after the Feb 28, 2026 report. 8 of 9 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $2.22 Now $2.17 −2.25% settles Feb 12
  2. Nov 13, 20263d ago 8-K Neutral 4/10 Entry $2.31 Now $2.17 −6.06% settles Feb 12
  3. Nov 12, 20264d ago Press Release Bearish 5/10 Entry $2.20 Now $2.17 +1.36% settles Feb 11
  4. Nov 3, 202613d ago 3 Neutral 1/10 Entry $2.31 Now $2.17 −6.06% settles Feb 2
  5. Nov 3, 202613d ago 3 Neutral 1/10 Entry $2.31 Now $2.17 −6.06% settles Feb 2
  6. Nov 3, 202613d ago 8-K Neutral 2/10 Entry $2.31 Now $2.17 −6.06% settles Feb 2
  7. Oct 26, 202621d ago Press Release Bullish 6/10 Entry $2.19 Now $2.17 −0.91% settles Jan 22
  8. Oct 23, 202624d ago 8-K Bullish 7/10 Entry $2.19 Now $2.17 −0.91% settles Jan 22
  9. Oct 22, 202625d ago 144 Neutral 2/10 Entry $2.25 Now $2.17 −3.56% settles Jan 21
  10. Oct 15, 20264w ago Press Release Neutral 3/10 Entry $3.25 Now $2.17 −33.23% settles Jan 13
Showing 10 of 21

US Market Status

Market Closed · Opens in 6h 38m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 11, 2026